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AIM: In our study, we investigated the levels of glutamic acid decarboxylase antibody (anti-GAD), islet cell antibody (ICA), thy-
roperoxidase antibody (anti-TPO), thyroglobulin antibody (anti-TG), antinuclear antibodies (FANA), antibodies to double-stranded 
DNA (anti-ds DNA), antibody to Sjögren syndrome A antigen (anti-SSA), antibody to Sjögren syndrome B antigen (anti-SSB), 
Smith antibody (anti-Sm), smooth muscle antibodies (ASMA), and antimitochondrial antibody liver-kidney microsome (AMA-
LKM) in patients with celiac disease as compared to healthy controls and autoimmune hypothyroid patients. 
MATERIALS AND METHODS: A total of 31 patients with celiac disease, 34 patients with autoimmune hypothyroidism and 29 
healthy subjects were included in this study. Anti-SSA, anti-SSB, anti-Sm, anti-ds DNA, anti-GAD, anti-TPO and anti-TG were 
studied by Enzyme-Linked Immunosorbent Assay (ELISA), and AMA-LKM, ASMA, ANA and ICA were studied by immunofluo-
rescence. Clinical data and the results of free thyroxine-thyroid stimulating hormone (FT4-TSH) were collected from the patients’ 
files by retrospective analysis. SPSS ver 13.0 was used for data analysis, and the χ2 method was used for comparisons within groups.
RESULTS: The frequency of anti-SSA, anti-SSB, anti-GAD, anti-Sm, anti-ds DNA, AMA-LKM, ASMA, ANA and ICA were 
not significantly different between the groups. Levels of anti-TPO and anti-TG antibodies were found to be significantly higher 
(<0.001) in autoimmune hypothyroid patients when compared with other groups.
CONCLUSION: In previous studies, an increased frequency of autoimmune diseases of other systems has been reported in pa-
tients with celiac disease. We found that the frequency of autoimmune antibodies specific for other autoimmune diseases was not 
higher in celiac disease. 
KEYWORDS: Celiac disease; Autoimmune diseases; Autoimmune hypothyroid patients; Autoimmune antibodies; Antinuclear 
antibodies.
INTRODUCTION
Celiac disease is a disease of autoimmune origin that 
affects the mucosa of the small intestine. It is characterized 
by a malabsorption profile that arises as a result of villus 
damage, which is caused by activation of the cellular and 
humoral immune system towards gluten, which is present in 
wheat, barley and rye. Today, it is accepted that individuals 
with celiac disease have an inborn genetic predisposition 
that then transforms into the disease under appropriate 
environmental conditions.1 At the outset, deterioration of 
the tight connections among the intestinal cells, which 
allows the antigenic structures in the lumen to pass, causes 
excess contact of these antigens with the mucosal immune 
system (such as antigen-producing cells). It is thought that, 
as the resulting immune response causes villus damage, it 
may also cause some other autoimmune diseases to arise.2 
The relationship between celiac and autoimmune diseases 
has been investigated in various studies. The association 
of celiac disease with systemic autoimmune diseases, such 1196
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as systemic lupus erythematosus and Sjögren’s syndrome, 
has been shown.3 Also, it is known that, in celiac disease, 
there is an increased frequency of endocrinological diseases 
of autoimmune etiology. Among these, in patients with 
autoimmune thyroiditis (Hashimoto’s thyroiditis, Graves’ 
disease), type I diabetes mellitus and Addison’s disease, 
the frequency of celiac disease is much higher than in 
the normal population.4–8 It is known that the above-
mentioned association is important in terms of disease 
treatment. For example, in type I diabetes mellitus that is 
accompanied by celiac disease, the celiac disease must be 
treated, particularly good blood glucose regulation, that 
is, a gluten-free diet must be followed. In individuals with 
Hashimoto’s thyroiditis or Graves’ disease, an inadequate 
treatment response should lead one to consider the presence 
of celiac disease.2 One cause of elevated transaminase, which 
may be present in the same diseases, may be subclinical 
celiac disease.1 An association between celiac disease and 
autoimmune hepatitis and primary biliary cirrhosis, which 
are autoimmune diseases of the hepatobiliary system, has 
been shown.9,10
The aim of our study was to research the frequency of 
autoantibodies in celiac disease patients who were monitored 
in the Gastroenterology Department, College of Medicine of 
Cerrahpaşa, İstanbul University. In our study, we researched 
the frequency of anti-GAD, anti-ICA, anti-TPO, anti-TG, 
FANA, anti-ds DNA, anti-SSA, anti-SSB, anti-Sm, AMA, 
ASMA, and LKM antibodies in celiac disease patients 
in comparison with healthy controls and patients with 
autoimmune hypothyroidism.
PATIENTS AND METHODS
A total of 31 patients with celiac disease who were 
diagnosed according to histopathological and/or serological 
criteria and 34 patients with autoimmune hypothyroidism 
(AHT) who were diagnosed according to serum FT4, TSH, 
anti-TPO and anti-TG levels11 participated in the study. The 
healthy control group consisted of 29 age- and sex-matched 
healthy subjects. All patients and controls were aged >18 years. 
All patients were accepted to the study after their approval. 
A volume of 10 ml of venous blood were taken from 
each patient in the morning, after fasting for 8 hours. 
The collected blood was centrifuged at 2,000 rpm for 10 
minutes to obtain sera. The sera were stored at –80°C until 
the study was completed. Patients and controls were asked 
about their age, duration of disease and treatment received 
and their hospital records were examined. We evaluated 
antibody levels among the diseased control group and 
healthy control group by using a EUROIMMUN ELISA 
kits (EUROIMMUN Medizinische Labordiagnostika AG: 
Germany). Anti-GAD IgG, anti-ds DNA IgG, anti-SSA IgG, 
anti-SSB IgG, anti-Sm IgG, anti-TPO IgG, anti-TG IgG, 
AMA-LKM IgG, ASMA IgG, ANA IgG and ICA IgG were 
studied with the methods described below. 
ELISA 
Semi-quantitative and quantitative ELISAs were used to 
measure anti-GAD, anti-ds DNA, anti-SSA, anti-SSB, anti-
Sm, anti-TPO, and anti-TG antibody levels in patient serum. 
In the semi-quantitative analysis, a ratio <1.0 was considered 
as negative and a ratio ≥1.0 was considered as positive. In 
the quantitative analysis, the threshold values specified by 
the kit manufacturer were accepted as positive. An anti-
TPO titer ≥50 IU/ml and an anti-TG titer ≥100 IU/ml were 
each accepted as positive. In the quantitative analysis, 
the threshold value specified by the kit manufacturer was 
taken for the GAD values found in the serum samples (an 
antibody level of ≥10 IU/ml was considered as positive). The 
ELISA washing steps were performed manually, whereas 
the reading process was carried out on Tecan Sunrise Touch 
Screen equipment. 
Immunofluorescence 
Patient sera were tested for AMA-LKM IgG, ANA IgG, 
ICA IgG and ASMA IgG. For the ANA test, human Hep 
20-10 and monkey hepatic cells were used as the substrate; 
for the ASMA test, rat gastric cells were used; for the ICA 
test, monkey pancreatic cells were used; for the AMA-LKM 
test, rat hepatic cells were used. The biochips were examined 
with a euroimmun eurostar microscope at 40× magnification. 
The results were evaluated as being positive or negative. 
The main evaluation criterion of the study was the 
frequency of the autoantibodies. The statistical analyses of 
the data obtained at the end of the evaluation period were 
carried out using Statistical Package for the Social Sciences 
(SPSS) ver. 13.0 for Windows (SPSS, Chicago, IL, USA). 
Comparisons of continuous variables were made by using 
Student’s t tests and one-way ANOVA followed by posthoc 
Tukey honestly significant differences (HSD) test and the 
results are given as mean ± SD, median, and interquartile 
range (IQR). For the categorical values, the χ² test was used. 
Our study was supported by the Department of Research 
Projects Budget of İstanbul University and approved by the 
Ethics Committee of College of Medicine of Cerrahpaşa, 
İstanbul University. 
RESULTS
The demographic features of the patients with celiac 1197
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disease, patients with AHT and healthy controls are 
summarized in Table 1.
The findings at patients’ first outpatient clinic visits are 
shown in Table 2.
Median gluten-free diet duration and time elapsed after 
diagnosis in patients with celiac disease were determined 
at 18 months [25%–75% IQR; (9–48)] and 30 months 
[25%–75% IQR; (18–60)], respectively. Median FT4 and 
TSH levels were determined as 1.04 ng/dL [25%–75% 
IQR; (0.89–1.12)] and 8.9 mIU/mL [25%–75% IQR; (5.66–
21.60)], respectively. 
Frequencies of antibody positivity are shown in Table 3. 
The additional diseases of patients with celiac disease 
are shown in Table 4. 
DISCUSSION 
In our study, we researched the frequency of antibodies 
that are specific for other autoimmune diseases in patients 
with celiac disease. Although the association of celiac 
disease with other diseases of autoimmune origin has been 
established, the frequency of antibodies that are specific for 
other autoimmune diseases in patients with celiac disease 
has not been investigated.
The association of autoimmune thyroid diseases (ATD) 
with celiac disease is well known. In genetically sensitive 
individuals, autoimmunity triggered by gluten may also 
cause the development of ATD. Although a specific influence 
of an HLA group has not been shown in ATD, it is known 
that, among the patients with celiac disease, the frequency of 
ATD is much greater in those with an HLA DQ2 haplotype.12 
Collin et al. determined the frequency of ATD to be 3.5% in 
patients with celiac disease and 2.7% in a control group; this 
difference was not significant.13 On the other hand, Ansaldi 
et al. found that, in 343 patients with celiac disease and 230 
controls, the frequency of ATD was 26.2% in the former and 
10% in the latter; this difference was significant (p<0.001).14 
In a similar study of 79 patients with celiac disease and 
184 healthy controls, which was carried out by Hakanen 
et al., the respective frequencies of positivity for anti-TPO 
antibody were 11.4 and 5.1%, respectively. 12 In the same 
study, the frequency of anti-TG antibody was found to be 
Table 1 - Demographic features of patients and healthy controls
Groups Patients with celiac disease  Patients with AHT  Healthy controls  p-value
Sex (M/W) 11/20 10/24 7/22 p=0.629 
Age (mean ± STD) years 38.32±12.58  39.79±10.02  36.13±10.02  p=0.525
Table 2 - Complaints of patients with celiac disease, prior 
to diagnosis
Complaint Number of patients (%)
Anemia  24 77.4
Diarrhea 24 77.4
Abdominal pain  23 74.2
Arthralgia 19 61.3
Constipation  15 48.4
Oral aphthous ulcer  10 32.3
Table 3 - Ratio of antibody positivity in groups
CD N=31 AHT N=34  HC N=29  x² P
ANA n (%) 4 (12.9) 9 (26.5) 4 (13.8) 2.536 0.281
ICA n (%) 1 (3.2) 1 (2.9) - 0.918 0.632
AMA-LKM  2 (6.5) - - 4.153 0.125
ASMA n (%) 1 (3.2) 2 (5.9) 2 (6.9) 0.434 0.805
SSA n (%) 2 (6.5) - - 4.153 0.125
SSB n (%) 2 (6.5) - - 4.153 0.125
TG n (%) - 23 (67.7)*§ 2 (6.9) 40.81 <0.001
TPO n (%) 3 (9.7) 29 (85.3)*§ 2 (6.9) 55.72 <0.001
SM n (%) - - - - -
GAD n (%) 1 (3.2) - -. 2.05 0.358
ds DNA n (%) - - - - -
CD: Celiac disease; HC: Healthy controls; AHT: Autoimmune hypothyroid patients; * Comparison between patients with AHT and celiac disease p≤0.05; 
§ Comparison between patients with AHT and healthy controls p≤0.051198
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8.8% in the patients with celiac disease and 5.1% in the 
healthy controls; a significant difference was not reached 
between the groups.12 For patients with celiac disease and 
controls, the respective antibody positivity frequencies 
were as follows: anti-TPO, 9 (11.4%) patients with celiac 
disease and 9 (5.1%) controls; anti-TG, 7 (8.8%) patients 
with celiac disease and 9 (5.1%) controls. Importantly, the 
differences were not statistically significant. The study of 
Collin et al. was retrospective and the other two studies were 
case–control studies.12-14
In our study, no significant difference was observed 
between the individuals with celiac disease and healthy 
controls in terms of the frequency of anti-TPO and anti-
TG positivity. Hakanen et al. did not observe a significant 
difference in terms of antibody positivity, and Collin et al. 
reported that clinical ATD was not increased in individuals 
with celiac disease. Therefore, both of these studies support 
our findings. 12, 13 
 In a study of individuals with celiac disease and their 
close relatives, patients with inflammatory intestinal 
diseases and healthy controls, Utiyema et al. investigated 
the frequency of antibodies to AMA, LKM and SMA. They 
did not find statistically different frequencies of positivity 
between individuals with celiac disease and healthy 
controls.15 In our study, we did not find that these antibodies 
were significantly increased in patients with celiac disease. 
In our retrospective analysis, we detected chronic liver 
disease of unknown etiology in one of our patients with 
celiac disease and transaminase elevation of undetermined 
etiology in five patients (6/31 patients, 19%). In another 
study, hepatic enzyme elevation unrelated to any known 
hepatic disease was reported in 114 children with celiac 
disease, for a rate of 32%.16 Since transaminase elevation at 
a frequency of 5–10% can be seen in individuals with celiac 
disease, celiac disease should be investigated in cases of 
transaminasemia of unknown cause. 
The autoimmunity triggered by gluten in genetically 
sensitive  individuals  may  cause  the  generation  of 
antibodies (e.g., anti-insulin and anti-B cell) against 
hidden autoantigens.1 This hypothesis may explain the high 
frequency of type 1 diabetes mellitus in individuals with 
celiac disease. In the literature, the frequency of ICA in 
patients with celiac disease is approximately 3% on average. 
In terms of the frequency of this antibody, a significant 
difference between individuals with celiac disease and 
healthy controls has not been reported.17,18 In our study, ICA 
and anti-GAD positivity were detected in only one patient 
with celiac disease (3.2%). ICA positivity was detected 
in one patient with AHT. In healthy controls, ICA and 
anti-GAD positivity were not detected, and a significant 
difference was not found in terms of the frequency of either 
autoimmune antibody among the three study groups. Aygün 
et al. reported that celiac disease has an increased frequency 
in patients with type 1 diabetes mellitus when compared 
with the normal population (2.45%).19 In our study, type 1 
diabetes mellitus was not detected in any of the patients with 
celiac disease.
In the literature, a high ratio of ANA positivity has been 
reported in individuals with celiac disease. In a study carried 
out by Utiyama et al. on 56 patients with celiac disease, 
their 118 first-degree relatives and 101 healthy controls, 
ANA was detected at a frequency of 9% in the group with 
celiac disease, whereas ANA positivity was not seen in any 
of the healthy controls (p=0.002).15 In our study, the ANA 
frequency was 12% (4/31) in the patients with celiac disease 
and 13.8% (4/29) in the healthy controls. There was no 
significant difference between the two groups. The results 
of studies in which ANA frequency in ATD was investigated 
are contradictory. In some studies, the ANA frequency in 
individuals with ATD was significantly higher than that in 
healthy individuals,20 whereas, in some other studies, the 
ANA frequency in patients with Hashimoto’s disease was 
not found to be significantly different from that in healthy 
controls.21 In our study, we did not detect a significant 
difference between the ANA frequency in individuals with 
AHT and healthy controls. 
In our study, anti-ds DNA positivity was not seen in any 
of the groups. Regarding this subject, diverse results have 
been reported in the literature. Lerner et al. have reported 
anti-ds DNA positivity of 23% (8/35) in patients with celiac 
disease.22 Another study reported an anti-ds DNA frequency 
Table 4 - Frequency of other diseases in patients with celiac 
disease
Additional diseases with celiac disease Number of 
patients
(%)
Hepatic dysfunction*  6 19.1
Dermatitis herpetiformis  2 6.5
Allergic diseases
(Bronchial asthma, anaphylaxis)  2 6.5
Endocrinopathy§  2 6.5
Psoriasis  1 3.2
Sarcoidosis 1 3.2
Connective tissue disease# 2 6.4
* Chronic liver disease of unknown etiology was determined in one patient. 
An increased transaminase level, with unknown origin was later determined 
in five patients. 
§ One patient had hypogonadotropic hypogonadism and the other one had 
diabetes insipidus.
# One patient had systemic lupus erythematosus and the other had Sjögren’s 
syndrome. The patient with systemic lupus erythematosus was positive for 
ANA, SSA and SSB antibodies. The patient with Sjögren’s syndrome was 
positive for SSA and SSB antibodies.1199
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in patients with Hashimoto’s to be significantly higher than 
in the control group (50%, p=0.0001).23
In all three groups evaluated in our study, no patients were 
positive for Sm antibody. As far as we are aware, there have 
been no previous studies of Sm antibody in patients with celiac 
disease. 
The association of Sjögren’s syndrome with celiac 
disease has been studied frequently. Anti-tTG and anti-
SSA/SSB may be found in the circulation of patients with 
Sjögren’s syndrome and celiac disease.24 Hansen et al. have 
found that the frequency of anti-SSB antibody frequency 
is higher in patients with autoimmune thyroidism than in 
healthy patients; however, they have not found the anti-SSA 
frequency to be different.25 In our study, SSA/SSB antibody 
was detected in 6.4% (2/31) of the patients with celiac 
disease and no significant difference was found between 
the groups. We did not detect anti-SSA or anti-SSB in any 
of the patients with AHT. One of the two patients who had 
positivity ANA, SSA,SSB antibodies had SLE and the other 
had Sjögren’s syndrome. Patinen et al. detected dry mouth 
in 40% of the individuals with celiac disease and reported 
that patients with celiac disease can develop sialadenitis, 
although it is not accompanied by Sjögren’s syndrome.26 
In another study, the frequency of celiac disease was 
investigated in 34 patients with Sjögren’s syndrome and a 
control group of 28 individuals, and the frequency of celiac 
disease was found to be 14.7% in patients with Sjögren’s 
syndrome.24 On the contrary, the frequency of Sjögren’s 
syndrome in individuals with celiac disease was reported 
as 3.3%. It was specified that this value was higher than the 
frequency in the group of healthy controls (p=0.0059).13
Our study has some limitations. We used a cross-
sectional approach and evaluated only patients who attended 
an outpatient clinic. Patients who had been on a gluten-free 
diet were checked for autoantibody frequency, which was 
not checked before switching to a gluten-free diet. A study 
by Sategna et al. demonstrated that long-term exposure of 
patients with celiac disease to gluten did not increase the 
prevalence of autoimmune diseases. Moreover, gluten-
free diets were shown not to prevent the development of 
autoimmune diseases.27 In another study involving patients 
diagnosed with late celiac disease, the duration of gluten 
exposure in adult celiac disease did not correlate with the 
risk of autoimmune disease, and gluten withdrawal did not 
protect patients from autoimmune disease.28 In view of these 
studies, we consider that it may be appropriate to check for 
autoantibodies under GFD.
In patients with celiac disease caused by genetic or 
environmental factors, the frequency of autoimmune diseases 
has increased. In our study, we determined that the frequency 
of autoantibodies that are specific for other autoimmune 
diseases were not elevated in patients with celiac disease. 
Our results may be explained by the fact that patients with 
celiac disease followed a gluten-free diet and that we had a 
small number of patients. However, we noticed an increased 
frequency of autoimmune disease in individuals with celiac 
disease when compared with those in the other two groups. 
Therefore, evaluation of patients with clinical and other 
laboratory methods is appropriate when existence of an 
additional autoimmune disease is suspected in patients with 
celiac disease, as opposed to solely evaluating autoimmune 
antibodies. 
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